Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy

Autor: Jan Paiul de Boer, Hans Gelderblom, Winette T. A. van der Graaf, Ad F. M. Snik, Robert P. Takes, Johannes H.A.M. Kaanders, Joop M. Leijendeckers, Carla M.L. van Herpen, Chantal M. L. Driessen

Publikováno v: Head and Neck : Journal for the Sciences and Specialties of the Head and Neck, 41, 2, pp. 488-494
Head and Neck, 41(2), 488-494
Head and Neck : Journal for the Sciences and Specialties of the Head and Neck, 41, 488-494

BACKGROUND This study evaluated ototoxicity in locally advanced head and neck cancer patients treated in the CONDOR study with docetaxel/cisplatin/5-fluorouracil (TPF) followed by conventional radiotherapy with concomitant cisplatin 100 mg/m2 on days

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::644aac705ef8fc65fdf21a0c4970b72b
https://pubmed.ncbi.nlm.nih.gov/30536479